Janssen’s initiatives in global public health complement the groundbreaking science of the Janssen Pharmaceutical Companies of Johnson & Johnson with innovative strategies that improve access to medicines, foster collaborations and support public health solutions to sustainably advance healthcare worldwide. It is responsible for a growing portfolio of pharmaceutical products and services to address the world’s greatest unmet public health needs. Key focus areas include multi-drug resistant tuberculosis (MDR-TB); HIV; neglected tropical diseases (NTDs) such as elephantiasis, river blindness and intestinal worms; and use of mobile technologies (mHealth) to improve health outcomes.
At Janssen, the Pharmaceutical Companies of Johnson & Johnson, we have a single overarching mission: to address and solve the most important unmet medical needs of our time.
Janssen aims to build on our strong legacy of innovation and dedication to improving global health to make a difference for patients and advance healthcare in society all over the world. Our passion and commitment run deep. We are driven to action by the plight of too many — we have heard their calls and aspire to make a positive impact on their lives.
Ultimately, we are changing how our business can deliver on the promise of our medicines, vaccines, diagnostics and services to address unmet public health needs across the world. We do this because we want to make a meaningful difference in global public health.